HAROLD PARTSCH: Open Payments
NPI 1831419878 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,245 in 177 payments from 23 companies in 2025. Trend: 2023 $1,466 · 2024 $1,745 · 2025 $2,245
Food & beverage: $2,245
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 75 | $478 |
| UCB, Inc. | 19 | $205 |
| EMD Serono, Inc. | 5 | $185 |
| ABBVIE INC. | 12 | $180 |
| ACADIA Pharmaceuticals Inc | 8 | $174 |
| Abbott Laboratories | 3 | $165 |
| Lundbeck LLC | 16 | $137 |
| Eisai Inc. | 7 | $132 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Neurocrine BioSciences, Inc. | 5 | $77 |
Products named: AUSTEDO XR, PROCLAIM, NUPLAZID, VYEPTI, Leqembi, QULIPTA, REXULTI, INGREZZA.
Industry payments across PA — which companies pay providers there.
